Association between Lipoprotein Subfractions, Hemostatic Potentials, and Coronary Atherosclerosis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association between Lipoprotein Subfractions, Hemostatic Potentials, and Coronary Atherosclerosis
Authors
Keywords
-
Journal
DISEASE MARKERS
Volume 2022, Issue -, Pages 1-7
Publisher
Hindawi Limited
Online
2022-08-31
DOI
10.1155/2022/2993309
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preclinical atherosclerosis and cardiovascular events: Do we have a consensus about the role of preclinical atherosclerosis in the prediction of cardiovascular events?
- (2022) Pavel Poredoš et al. ATHEROSCLEROSIS
- Challenges and Opportunities on Lipid Metabolism Disorders Diagnosis and Therapy: Novel Insights and Future Perspective
- (2021) Zlatko Fras et al. Metabolites
- High-Density Lipoprotein Subfractions: Much Ado about Nothing or Clinically Important?
- (2021) Knut Tore Lappegård et al. Biomedicines
- Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
- (2020) Jan Borén et al. EUROPEAN HEART JOURNAL
- HDL-C is associated with mortality from all causes, cardiovascular disease and cancer in a J-shaped dose-response fashion: a pooled analysis of 37 prospective cohort studies
- (2020) Guo-Chao Zhong et al. European Journal of Preventive Cardiology
- HDL Subclass Analysis in Predicting Metabolic Syndrome in Koreans With High HDL Cholesterol Levels
- (2020) Hyun Suk Yang et al. Annals of Laboratory Medicine
- High-density Lipoprotein-cholesterol Subfractions and Coronary Artery Calcium: The ELSA-Brasil Study
- (2019) Giuliano Generoso et al. ARCHIVES OF MEDICAL RESEARCH
- Biological variation estimates of prothrombin time, activated partial thromboplastin time, and fibrinogen in 28 healthy individuals
- (2018) Mesude Falay et al. International Journal of Laboratory Hematology
- Association between fibrinogen level and the severity of coronary stenosis in 418 male patients with myocardial infarction younger than 35 years old
- (2017) Xiong-Yi Gao et al. Oncotarget
- Lipoproteins as modulators of atherothrombosis: From endothelial function to primary and secondary coagulation
- (2016) Amber B. Ouweneel et al. VASCULAR PHARMACOLOGY
- Influence of Blood Lipids on Global Coagulation Test Results
- (2015) Jung-Ah Kim et al. Annals of Laboratory Medicine
- HDL2-cholesterol/HDL3-cholesterol ratio was associated with insulin resistance, high-molecular-weight adiponectin, and components for metabolic syndrome in Japanese
- (2014) Kengo Moriyama et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- The Value and Distribution of High-Density Lipoprotein Subclass in Patients with Acute Coronary Syndrome
- (2014) Li Tian et al. PLoS One
- Association of high-density lipoprotein subclasses and incident coronary heart disease: The Jackson Heart and Framingham Offspring Cohort Studies
- (2014) Parag H Joshi et al. European Journal of Preventive Cardiology
- Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond
- (2013) Amy S. Shah et al. JOURNAL OF LIPID RESEARCH
- Hemostatic Factors and Risk of Coronary Heart Disease in General Populations: New Prospective Study and Updated Meta-Analyses
- (2013) Peter Willeit et al. PLoS One
- Detection of hypofibrinolysis in stable coronary artery disease using the overall haemostatic potential assay
- (2013) Caroline J. Reddel et al. THROMBOSIS RESEARCH
- Protein C anticoagulant and cytoprotective pathways
- (2012) John H. Griffin et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Accelerated In Vivo Thrombin Formation Independently Predicts the Presence and Severity of CT Angiographic Coronary Atherosclerosis
- (2012) Julian I. Borissoff et al. JACC-Cardiovascular Imaging
- Increased coagulation factor VIII activity in patients with familial hypercholesterolemia
- (2011) R. Huijgen et al. BLOOD
- Residual Cardiovascular Risk Despite Optimal LDL Cholesterol Reduction with Statins: The Evidence, Etiology, and Therapeutic Challenges
- (2011) Uchechukwu K. Sampson et al. Current Atherosclerosis Reports
- Prospective study of coronary heart disease vs. HDL2, HDL3, and other lipoproteins in Gofman's Livermore Cohort
- (2010) Paul T. Williams et al. ATHEROSCLEROSIS
- High-density lipoproteins, platelets and the pathogenesis of atherosclerosis
- (2010) Jerzy-Roch Nofer et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- HDL3, but not HDL2, stimulates plasminogen activator inhibitor-1 release from adipocytes: the role of sphingosine-1-phosphate
- (2010) Mi-Hye Lee et al. JOURNAL OF LIPID RESEARCH
- The Overall Hemostasis Potential: A Laboratory Tool for the Investigation of Global Hemostasis
- (2010) Aleksandra Antovic SEMINARS IN THROMBOSIS AND HEMOSTASIS
- A comprehensive definition for metabolic syndrome
- (2009) P. L. Huang Disease Models & Mechanisms
- Screening Haemostasis – Looking for Global Assays: The Overall Haemostasis Potential (OHP) Method – A Possible Tool for Laboratory Investigation of Global Haemostasis in Both Hypo- and Hypercoagulable Conditions
- (2008) Aleksandra Antovic Current Vascular Pharmacology
- The metabolism and anti-atherogenic properties of HDL
- (2008) Kerry-Anne Rye et al. JOURNAL OF LIPID RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation